| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-065652 |
| cik | 1369568 |
| name | CATALYST PHARMACEUTICALS, INC. |
| sic | 2834 |
| countryba | US |
| stprba | FL |
| cityba | CORAL GABLES |
| zipba | 33134 |
| bas1 | 355 ALHAMBRA CIRCLE |
| bas2 | SUITE 801 |
| baph | (305) 529-2522 |
| countryma | US |
| stprma | FL |
| cityma | CORAL GABLES |
| zipma | 33134 |
| mas1 | 355 ALHAMBRA CIRCLE |
| mas2 | SUITE 801 |
| countryinc | US |
| stprinc | DE |
| ein | 000000000 |
| former | CATALYST PHARMACEUTICAL PARTNERS, INC. |
| changed | 20110215 |
| afs | 1-LAF |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250507 |
| accepted | 2025-05-07 16:10:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | cprx-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-065652 | 20250331 | Accounts Receivable Net Current | 71265000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Accounts Payable Current | 16593000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Accounts Receivable Net Current | 65476000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Accretion Of Discount | -153000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20240331 | Amortization Of Intangible Assets | 9344000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Amortization Of Intangible Assets | 9345000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Cash And Cash Equivalents At Carrying Value | 580656000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Increase Decrease In Accounts Receivable | 6979000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 8474000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -2552000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Interest Paid Net | 65000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Liabilities And Stockholders Equity | 908872000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Liabilities Current | 120678000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Net Cash Provided By Used In Financing Activities | 3060000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Net Income Loss | 23275000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Net Income Loss | 56737000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065652 | 20250331 | Non Cash Change In Right Of Use Asset | 72000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20250331 | Operating Lease Right Of Use Asset | 2158000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -81000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Payment Of Liabilities Arising From Asset Acquisition | 973000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20231231 | Proceeds From Issuance Of Common Stock | 140700000.0000 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Public Offering; | ||
| 0000950170-25-065652 | 20250331 | Profit Loss | 56737000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Research And Development Expense | 2581000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Retained Earnings Accumulated Deficit | 341898000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 30425000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Fycompa; | ||
| 0000950170-25-065652 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 141400000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product Revenue Net; | ||
| 0000950170-25-065652 | 20250331 | Selling General And Administrative Expense | 46911000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Share Based Compensation | 5425000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Selling General And Administrative Expenses; | ||
| 0000950170-25-065652 | 20241231 | Shares Outstanding | 120879000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20240331 | Stockholders Equity | 118000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20240331 | Stockholders Equity | 144547000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065652 | 20250331 | Stockholders Equity | 452280000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20231231 | Stock Issued During Period Shares New Issues | 10000000.0000 | shares | 0 | us-gaap/2024 | Registration Payment Arrangement By Arrangement= Two Thousand Twenty Three Shelf Registration Statement; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 664432.0000 | shares | 1 | us-gaap/2024 | Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities= Options To Purchase Common Stock; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 664000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 975000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5850000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Assets | 851411000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Assets | 908872000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Assets Current | 623609000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Comprehensive Income Net Of Tax | 23261000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Cost Of Goods And Services Sold | 17911000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Equity Securities F V N I Noncurrent | 21564000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0000950170-25-065652 | 20241231 | Finite Lived Intangible Assets Net | 156672000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Finite Lived Intangible Assets Net | 27250000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= License And Acquired Intangibles For R U Z U R G I; | ||
| 0000950170-25-065652 | 20250331 | Income Tax Expense Benefit | 14549000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Increase Decrease In Accounts Payable | -4534000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Interest Paid Net | 103000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Net Cash Provided By Used In Investing Activities | -199000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | 25000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Other Nonoperating Income Expense | 1963000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Payments To Acquire Property Plant And Equipment | 199000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Prepaid Expense And Other Assets Current | 21039000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Selling General And Administrative Expense | 46938000.0000 | USD | 1 | us-gaap/2024 | exclusive of amortization of intangible assets | ||
| 0000950170-25-065652 | 20250331 | Shares Outstanding | 121959000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20241231 | Stockholders Equity | 64000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065652 | 20241231 | Stockholders Equity | 121000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20250331 | Stockholders Equity | 122000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 105000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -204000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 121472468.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Finite Lived Intangible Assets Net | 27830000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= License And Acquired Intangibles For R U Z U R G I; | ||
| 0000950170-25-065652 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 64000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 310411000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 172775000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Deferred Income Tax Assets Net | 45982000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Earnings Per Share Basic | 0.2000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Finite Lived Intangible Assets Net | 88934000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= License And Acquired Intangibles For Fycompa; | ||
| 0000950170-25-065652 | 20240331 | Increase Decrease In Deferred Income Taxes | 1746000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Increase Decrease In Operating Lease Liability | -97000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -7020000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Inventory Net | 19541000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Liabilities | 123779000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Liabilities And Stockholders Equity | 851411000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Net Cash Provided By Used In Financing Activities | 141049000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Operating Lease Liability Noncurrent | 2786000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Other Comprehensive Income Loss Net Of Tax | -81000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Other Liabilities Noncurrent | 259000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Payments Of Stock Issuance Costs | 296000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Payments To Acquire Property Plant And Equipment | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20231231 | Proceeds From Issuance Of Common Stock | 140700000.0000 | USD | 0 | us-gaap/2024 | Registration Payment Arrangement By Arrangement= Two Thousand Twenty Three Shelf Registration Statement; | ||
| 0000950170-25-065652 | 20240331 | Profit Loss | 23275000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 98441000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product Revenue Net; | ||
| 0000950170-25-065652 | 20240331 | Share Based Compensation | 509000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0000950170-25-065652 | 20250331 | Share Based Compensation | 425000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0000950170-25-065652 | 20250331 | Stockholders Equity | 794283000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20231231 | Stock Issued During Period Shares New Issues | 10000000.0000 | shares | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Public Offering; | ||
| 0000950170-25-065652 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20250331 | Accretion Of Discount | 60000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20240331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Additional Paid In Capital | 442286000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 8248000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 8248000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20240331 | Amortization Of Intangible Assets | 7900000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= License And Acquired Intangibles For Fycompa; | ||
| 0000950170-25-065652 | 20240331 | Amortization Of Intangible Assets | 600000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= License And Acquired Intangibles For R U Z U R G I; | ||
| 0000950170-25-065652 | 20241231 | Cash And Cash Equivalents At Carrying Value | 517553000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Common Stock Shares Issued | 120879099.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Common Stock Shares Outstanding | 121959172.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Common Stock Value | 122000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Equity Securities Fv Ni Gain Loss | 2644000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Income Taxes Paid | 639000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Increase Decrease In Deferred Income Taxes | 2321000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Other Comprehensive Income Loss Net Of Tax | -81000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065652 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Proceeds From Stock Options Exercised | 4787000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Retained Earnings Accumulated Deficit | 285161000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 22042000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Agamree; | *AGAMREE net product revenue for the three months ended March 31, 2024 is for the period between March 13, 2024 (date of commercial launch) and March 31, 2024. | |
| 0000950170-25-065652 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 83731000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Firdapse; | ||
| 0000950170-25-065652 | 20240331 | Shares Outstanding | 118030000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20231231 | Stockholders Equity | 387881000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20231231 | Stockholders Equity | 107000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20250331 | Stockholders Equity | -17000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Value New Issues | 10000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20240331 | Increase Decrease In Inventories | 4309000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Additional Paid In Capital | 452280000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Amortization Of Intangible Assets | 900000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Licensed And Acquired Intangibles For Agamree; | ||
| 0000950170-25-065652 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 63103000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-065652 | 20241231 | Common Stock Value | 121000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Depreciation | 115000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Equity Securities F V N I Noncurrent | 21564000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Finite Lived Intangible Assets Net | 32000000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Licensed And Acquired Intangibles For Agamree; | ||
| 0000950170-25-065652 | 20250331 | Increase Decrease In Accounts Receivable | 5789000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Inventory Net | 19778000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Liabilities | 114589000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Net Income Loss | 56737000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Operating Expense | 71383000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20250331 | Operating Lease Liability Noncurrent | 2681000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -14000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065652 | 20250331 | Other Nonoperating Income Expense | 7919000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Prepaid Expense And Other Assets Current | 14019000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Property Plant And Equipment Net | 1354000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1174000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Agamree; | ||
| 0000950170-25-065652 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 68000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= License And Other Revenue; | ||
| 0000950170-25-065652 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 21000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= License And Other Revenue; | ||
| 0000950170-25-065652 | 20231231 | Stockholders Equity | 14000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065652 | 20231231 | Stockholders Equity | 266488000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 244000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 975155.0000 | shares | 1 | us-gaap/2024 | Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities= Options To Purchase Common Stock; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Value New Issues | 140704000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -642000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 1522000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 4786000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20240331 | Net Cash Provided By Used In Operating Activities | 31925000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Operating Expense | 78054000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20241231 | Operating Lease Right Of Use Asset | 2230000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Payment Of Liabilities Arising From Asset Acquisition | 1085000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 642000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Proceeds From Stock Options Exercised | 1522000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Research And Development Expense | 3887000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 141421000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 35627000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Fycompa; | ||
| 0000950170-25-065652 | 20241231 | Stockholders Equity | 727632000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Shares New Issues | 10000000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -204000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -642000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 4787000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20231231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 14000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -17000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Amortization Of Intangible Assets | 900000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Licensed And Acquired Intangibles For Agamree; | ||
| 0000950170-25-065652 | 20250331 | Assets Current | 685718000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 517553000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Comprehensive Income Net Of Tax | 56656000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Earnings Per Share Diluted | 0.4500 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Equity Securities Fv Ni Gain Loss | -1144000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Equity Securities F V N I Noncurrent | 24208000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0000950170-25-065652 | 20250331 | Finite Lived Intangible Assets Net | 31143000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Licensed And Acquired Intangibles For Agamree; | ||
| 0000950170-25-065652 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 29089000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Income Tax Expense Benefit | 5814000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Increase Decrease In Inventories | 237000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Increase Decrease In Operating Lease Liability | -89000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Net Income Loss | 23275000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065652 | 20240331 | Operating Income Loss | 27126000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Operating Income Loss | 63367000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Payments Of Stock Issuance Costs | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Proceeds From Issuance Of Common Stock | 141000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Proceeds From Stock Options Exercised | 1500000.0000 | USD | 1 | us-gaap/2024 | Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities= Options To Purchase Common Stock; | ||
| 0000950170-25-065652 | 20250331 | Property Plant And Equipment Net | 1239000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 98509000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 66842000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Firdapse; | ||
| 0000950170-25-065652 | 20250331 | Share Based Compensation | 5850000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20231231 | Shares Outstanding | 107122000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-065652 | 20231231 | Stockholders Equity | 121272000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065652 | 20240331 | Stockholders Equity | 561412000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Stockholders Equity | 416747000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20241231 | Stockholders Equity | 442286000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Value New Issues | 140694000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 123403626.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Common Stock Shares Outstanding | 120879099.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Depreciation | 86000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Equity Securities F V N I Noncurrent | 24208000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Accrued Liabilities Current | 104085000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Accrued Liabilities Current | 100452000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Amortization Expenses Of Intangible Asset | 9344000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20250331 | Amortization Expenses Of Intangible Asset | 9345000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20250331 | Amortization Of Intangible Assets | 7900000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= License And Acquired Intangibles For Fycompa; | ||
| 0000950170-25-065652 | 20250331 | Amortization Of Intangible Assets | 600000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= License And Acquired Intangibles For R U Z U R G I; | ||
| 0000950170-25-065652 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 137636000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 580656000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Finite Lived Intangible Assets Net | 147327000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 71286000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Increase Decrease In Accounts Payable | -5396000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 1210000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Liabilities Current | 111649000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Net Cash Provided By Used In Investing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Net Cash Provided By Used In Operating Activities | 60043000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Non Cash Change In Right Of Use Asset | 68000.0000 | USD | 1 | 0000950170-25-065652 | |||
| 0000950170-25-065652 | 20241231 | Other Liabilities Noncurrent | 315000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 204000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Proceeds From Stock Options Exercised | 4800000.0000 | USD | 1 | us-gaap/2024 | Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities= Options To Purchase Common Stock; | ||
| 0000950170-25-065652 | 20240331 | Share Based Compensation | 8248000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Share Based Compensation | 7739000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Selling General And Administrative Expenses; | ||
| 0000950170-25-065652 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-065652 | 20241231 | Stockholders Equity | 285161000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065652 | 20250331 | Stockholders Equity | 341898000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-065652 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 1521000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 126957982.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 116806117.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Accounts Payable Current | 11197000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5850000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-065652 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-065652 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Common Stock Shares Issued | 121959172.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Cost Of Goods And Services Sold | 12520000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Deferred Income Tax Assets Net | 48222000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20250331 | Earnings Per Share Basic | 0.4700 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20240331 | Earnings Per Share Diluted | 0.1900 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-065652 | 20241231 | Finite Lived Intangible Assets Net | 96842000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= License And Acquired Intangibles For Fycompa; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Equity Securities F V N I Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Equity Securities, FV-NI, Noncurrent | Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as noncurrent. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Deferred Income Tax Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Income Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Amortization Expenses Of Intangible Asset | 0000950170-25-065652 | 1 | 0 | monetary | D | D | Amortization Expenses of Intangible Asset | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Operating Expense | 0000950170-25-065652 | 1 | 0 | monetary | D | D | Operating Expense | Operating expense. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Income Taxes Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid | Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. | |
| Finite Lived Intangible Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
| Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
| Increase Decrease In Deferred Income Taxes | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Deferred Income Taxes | The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Non Cash Change In Right Of Use Asset | 0000950170-25-065652 | 1 | 0 | monetary | D | D | Non cash change in right of use asset | Amount of cash change in right of use asset. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accretion Of Discount | 0000950170-25-065652 | 1 | 0 | monetary | D | C | Accretion Of Discount | The amount represents accretion of discount. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Equity Securities Fv Ni Gain Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Equity Securities, FV-NI, Gain (Loss) | Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Payment Of Liabilities Arising From Asset Acquisition | 0000950170-25-065652 | 1 | 0 | monetary | D | C | Payment Of Liabilities Arising From Asset Acquisition | Payment of liabilities arising from asset acquisition. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | us-gaap/2024 | 0 | 0 | monetary | D | D | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-065652 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-065652 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0000950170-25-065652 | 2 | 5 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory | 0 |
| 0000950170-25-065652 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-065652 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-065652 | 2 | 8 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use asset, net | 0 |
| 0000950170-25-065652 | 2 | 9 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-065652 | 2 | 10 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2024 | License and acquired intangibles, net | 0 |
| 0000950170-25-065652 | 2 | 11 | BS | 0 | H | Deferred Income Tax Assets Net | us-gaap/2024 | Deferred tax assets, net | 0 |
| 0000950170-25-065652 | 2 | 12 | BS | 0 | H | Equity Securities F V N I Noncurrent | us-gaap/2024 | Investment in equity securities | 0 |
| 0000950170-25-065652 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-065652 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-065652 | 2 | 17 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0000950170-25-065652 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-065652 | 2 | 19 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, net of current portion | 0 |
| 0000950170-25-065652 | 2 | 20 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other non-current liabilities | 0 |
| 0000950170-25-065652 | 2 | 21 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-065652 | 2 | 22 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 12) | 0 |
| 0000950170-25-065652 | 2 | 24 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.001 par value, 5,000,000 shares authorized: none issued and outstanding at March 31, 2025 and December 31, 2024 | 0 |
| 0000950170-25-065652 | 7 | 13 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventory | 1 |
| 0000950170-25-065652 | 2 | 25 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value, 200,000,000 shares authorized; 121,959,172 shares and 120,879,099 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0000950170-25-065652 | 2 | 26 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-065652 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Retained earnings | 0 |
| 0000950170-25-065652 | 2 | 28 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income (loss) (Note 4) | 0 |
| 0000950170-25-065652 | 2 | 29 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0000950170-25-065652 | 2 | 30 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0000950170-25-065652 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0000950170-25-065652 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0000950170-25-065652 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0000950170-25-065652 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0000950170-25-065652 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0000950170-25-065652 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0000950170-25-065652 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0000950170-25-065652 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0000950170-25-065652 | 4 | 8 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Total revenues | 0 |
| 0000950170-25-065652 | 4 | 10 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of sales | 0 |
| 0000950170-25-065652 | 4 | 11 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-065652 | 4 | 12 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative | 0 |
| 0000950170-25-065652 | 4 | 13 | IS | 0 | H | Amortization Expenses Of Intangible Asset | 0000950170-25-065652 | Amortization of intangible assets | 0 |
| 0000950170-25-065652 | 4 | 14 | IS | 0 | H | Operating Expense | 0000950170-25-065652 | Total operating costs and expenses | 0 |
| 0000950170-25-065652 | 4 | 15 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating income | 0 |
| 0000950170-25-065652 | 4 | 16 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income, net | 0 |
| 0000950170-25-065652 | 4 | 17 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Net income before income taxes | 0 |
| 0000950170-25-065652 | 4 | 18 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax provision | 0 |
| 0000950170-25-065652 | 4 | 19 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0000950170-25-065652 | 4 | 21 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic | 0 |
| 0000950170-25-065652 | 4 | 22 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted | 0 |
| 0000950170-25-065652 | 4 | 24 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic | 0 |
| 0000950170-25-065652 | 4 | 25 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted | 0 |
| 0000950170-25-065652 | 4 | 26 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0000950170-25-065652 | 4 | 28 | IS | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized gain (loss) on available-for-sale securities, net of tax of $4 and $4, respectively | 0 |
| 0000950170-25-065652 | 4 | 29 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive income | 0 |
| 0000950170-25-065652 | 5 | 1 | IS | 1 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | us-gaap/2024 | Net of tax impact | 0 |
| 0000950170-25-065652 | 6 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
| 0000950170-25-065652 | 6 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning Balance (shares) | 0 |
| 0000950170-25-065652 | 6 | 11 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock, net | 0 |
| 0000950170-25-065652 | 6 | 12 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock, net (shares) | 0 |
| 0000950170-25-065652 | 6 | 13 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-065652 | 6 | 14 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options for common stock | 0 |
| 0000950170-25-065652 | 6 | 15 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options for common stock (shares) | 0 |
| 0000950170-25-065652 | 6 | 16 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | Issuance of common stock upon vesting of restricted stock units, net | 0 |
| 0000950170-25-065652 | 6 | 17 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | Issuance of common stock upon vesting of restricted stock units, net (Share) | 0 |
| 0000950170-25-065652 | 6 | 18 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Other comprehensive gain (loss) | 0 |
| 0000950170-25-065652 | 6 | 19 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0000950170-25-065652 | 6 | 20 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
| 0000950170-25-065652 | 6 | 21 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending Balance (shares) | 0 |
| 0000950170-25-065652 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net income | 0 |
| 0000950170-25-065652 | 7 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0000950170-25-065652 | 7 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-065652 | 7 | 6 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangible assets | 0 |
| 0000950170-25-065652 | 7 | 7 | CF | 0 | H | Increase Decrease In Deferred Income Taxes | us-gaap/2024 | Deferred taxes | 1 |
| 0000950170-25-065652 | 7 | 8 | CF | 0 | H | Accretion Of Discount | 0000950170-25-065652 | Accretion of discount | 1 |
| 0000950170-25-065652 | 7 | 9 | CF | 0 | H | Non Cash Change In Right Of Use Asset | 0000950170-25-065652 | Reduction in the carrying amount of right-of-use asset | 0 |
| 0000950170-25-065652 | 7 | 10 | CF | 0 | H | Equity Securities Fv Ni Gain Loss | us-gaap/2024 | Change in fair value of equity securities | 1 |
| 0000950170-25-065652 | 7 | 12 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable, net | 1 |
| 0000950170-25-065652 | 7 | 14 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0000950170-25-065652 | 7 | 16 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-065652 | 7 | 17 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0000950170-25-065652 | 7 | 18 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liability | 0 |
| 0000950170-25-065652 | 7 | 19 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash provided by (used in) operating activities | 0 |
| 0000950170-25-065652 | 7 | 21 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0000950170-25-065652 | 7 | 22 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by (used in) investing activities | 0 |
| 0000950170-25-065652 | 7 | 24 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | Payment of employee withholding tax related to stock-based compensation | 1 |
| 0000950170-25-065652 | 7 | 25 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of stock options | 0 |
| 0000950170-25-065652 | 7 | 26 | CF | 0 | H | Payment Of Liabilities Arising From Asset Acquisition | 0000950170-25-065652 | Payment of liabilities arising from asset acquisition | 1 |
| 0000950170-25-065652 | 7 | 27 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuance of common stock | 0 |
| 0000950170-25-065652 | 7 | 28 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Payment of fees in connection with issuance of common stock | 1 |
| 0000950170-25-065652 | 7 | 29 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by (used in) financing activities | 0 |
| 0000950170-25-065652 | 7 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash and cash equivalents | 0 |
| 0000950170-25-065652 | 7 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents beginning of period | 0 |
| 0000950170-25-065652 | 7 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents end of period | 0 |
| 0000950170-25-065652 | 7 | 34 | CF | 0 | H | Income Taxes Paid | us-gaap/2024 | Cash paid for income taxes | 0 |
| 0000950170-25-065652 | 7 | 35 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |